Synthesis and in vitro drug release studies on substituted polyphosphazene conjugates of lumefantrine
Keywords:
polyphosphazene, lumefantrine, conjugate, malaria, p-amino benzoic acid esterAbstract
The present study pertains to the delivery of antimalarial drug (Lumifantrine). In this, polyphosphazene has been used in the synthesis of polyphosphazene-linked conjugates of Lumifantrine. These polymer-linked Conjugates have been synthesized and characterized by modern analytical techniques. The in-vitro drug release of Lumifantrine drug conjugates: p-Amino benzoic acid ester substituted polyphosphazene drug conjugate (15) and Glycine methyl ester substituted polyphosphazene drug conjugate (21) have been found to be 6.00 % and 5.96% (pH 1.2), 88.52% and 79.86% (pH7.4), respectively. These drugs conjugate may prove an effective delivery system for the treatment of malaria.
References
. World health organization. The World Health Report. Conquering, Suffering, Enriching Humanity. Geneva; World Health Organisation Publisher; 1997.
. Ashley E, Gready RM, Proux F. Malaria. Travel Med.Infect.Dis.2006; 11:159.
. Lalloo DG. Malaria in adolescence: burden of disease, consequences and opportunities for intervention. Lancet Infect. Dis.2006;6:780.
. Snow RW, Trape JF, Marsh K. The past, present and future of childhood malaria mortality in Africa. Trends Parasitol. 2001; 17: 593.
. Breman JG. The ears of the hippopotamus:manifestations,determinants, and estimates of the malaria burden. Am. J. Trop. Med. Hyg. 2001; 64:1.
. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR. Epidemiology of drug-resistant malaria. Lancet Infect. Des. 2002; 2: 209.
. White NJ. Antimalarial drug resistance: the pace quickens. J Antimicrob. Chemother. 1992; 30: 571.
. Foley M, Tilley L. Home improvements: malaria and the red cell. Parasitol Today. 1995; 11: 436-9.
. Grau GE, De Kossodo S. Cerebral malaria: mediators, mechanical obstruction or more? Parasitol Today. 1994; 10: 408-9.
. Saini S, Singh G, Kalara N, Singh CG, Virmani T. Development of nanostructured liquid crystalline formulation of antimalarial agents artemether and lumifantrine. World Journal of pharmaceutical research. 2015;4.
. Liebig J, Wohler F. Justus Leibigs Ann. Chem. 1834;11:139.
. Lakshmi S, Katti DS, Laurencin CT. Adv. Drug. Deliv. Rev. 2003; 55:467.
. Song SC, Sohn YSJ. Control. Rel. 1998;55:161.
. Schacht E, Vandrope J, Lemmouchi Y, Dejardin S, Seymour L. Frontiers in Biomed. Polym. Appl. Technomic Publishing Co. Inc. Lancaster. 1998; 27.
. Gleria M. Chem. Ind.1988; 70: 15.
. Shriver DFM, Tonge JS, Barriola A, Allcock HR, Blonsky PM. Polym. Prepr. 1987; 28: 438.
. Allcock HR. Macromolecules.1979; 12: 1130.
. Sohan YS, Cho YS, Baek H, Jung. Synthesis and properties of low molecular weight Polyphosphazenes macromolecules. 1995; 28: 7566-7568.
. Mann FG, Saunders BC. Practical organic chemictry. Pearson education limited. 1973; 244-245.
. Dahiya A. Synthesis, characterization and biological evaluation of a glycine-richpeptide-cherimolacyclopeptide. J. Chil. Chem. Soc. 2007; 52: 3.
. Spezzacatena C, Perri T, Guantieri V, Sandberg L.B, Mitts T.F, Tamburro A.M, et al. Eur. J. Org. Chem. 2002; 1: 95.
